Pharmaceuticals

Non-Therapeutic Biomolecules Market Forecast Showing Industry Progress And Growth Trends

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Non-Therapeutic Biomolecules Market Grow Between 2026 And 2030?

The non-therapeutic biomolecules market has experienced rapid expansion in recent years. It is projected to grow from $33.92 billion in 2025 to $37.59 billion in 2026, at a compound annual growth rate (CAGR) of 10.8%. This historical growth can be attributed to several factors, including the rising demand for research biomolecules, increased adoption in in vitro diagnostics, growth within pharmaceutical research, advancements in recombinant protein technology, and an increase in collaborations between biotech firms.

The non-therapeutic biomolecules market is poised for significant expansion in the coming years. Projections indicate it will reach a size of $56.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This growth during the forecast period is primarily driven by several factors, including the proliferation of synthetic biomolecule applications, increased financial backing for precision medicine, wider adoption in agricultural biotechnology, a heightened emphasis on environmentally friendly and scalable methods for biomolecule production, and advancements in automated biomolecule synthesis technologies. Key developments anticipated within the same period encompass sophisticated protein engineering, high-throughput screening methodologies, sustainable approaches to biomolecule creation, cell-free biomolecule synthesis, and adaptable biomolecule platforms.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

What Significant Factors Are Influencing The Non-Therapeutic Biomolecules Market Expansion?

The non-therapeutic biomolecules market is anticipated to expand due to the escalating volume of research and laboratory testing. Laboratory testing refers to medical procedures that involve analyzing samples of blood, urine, or other substances from the body to diagnose and monitor diseases and to formulate treatment strategies. Conversely, research involves creating new knowledge or creatively applying existing knowledge to develop new concepts, theories, and understandings. In laboratory testing, non-therapeutic biomolecules are employed to measure the presence or concentration of biomarker molecules that indicate disease, thereby enhancing the sensitivity and specificity of the tests. For instance, in July 2024, the National Health Service (NHS), a UK-based hospital and health care provider, reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% increase in tests performed in May 2024 compared to 2023. Consequently, the rapidly increasing number of research and laboratory testing is driving the growth of the non-therapeutic biomolecules market.

How Is The Non-Therapeutic Biomolecules Market Segmented Across Different Segment Categories?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

3) By Application: Diagnostic Equipment, Therapeutic Equipment, Monitoring Or Imaging Equipment, Laboratory Or Research Equipment, Rehabilitation Or Mobility Support

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

What Trends Are Affecting The Direction Of The Non-Therapeutic Biomolecules Market?

Leading companies in the non-therapeutic biomolecules market are prioritizing the development of new cell separation technology to boost throughput and refine processes, thereby gaining a competitive advantage. This innovative kit, intended solely for research, aims to provide scientists with an essential answer to biological and lab workflow challenges. For instance, in May 2023, AcouSort AB, a biotechnology firm from Sweden, introduced the AcouTrap 3 system. This system integrates the distinct properties of acoustofluidics, merging sound waves with microfluidics, to present an efficient method for isolating cells and extracellular vesicles within a single operational sequence. The AcouTrap 3 system utilizes gentle acoustic trapping technology, allowing scientists to process a greater number of samples with enhanced cell viability and reduced loss compared to conventional column- or bead-based techniques, consequently improving productivity and optimizing laboratory functions.

Which Organizations Play A Role In The Non-Therapeutic Biomolecules Market Landscape?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Eppendorf AG, Bio-Techne Corporation, Vectalys, Avid Bioservices Inc.

Get The Full Non-Therapeutic Biomolecules Market Report:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Where Is The Non-Therapeutic Biomolecules Market Most Concentrated Geographically?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2025. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Non-Therapeutic Biomolecules Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Browse Through More Reports Similar to the Global Non-Therapeutic Biomolecules Market 2026, By The Business Research Company

Non Therapeutic Biomolecules Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Bioengineered Protein Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioengineered-protein-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795